TechTaffy

tech:

taffy

Atomwise enters into an evaluation agreement with Pfizer

By TechTaffy Desk

Atomwise has entered into an evaluation agreement with Pfizer, in which the drug giant will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins selected by Pfizer.

Atomwise will computationally analyze millions of diverse small molecules for each of Pfizer’s identified target proteins using its AI platform, to predict those that may bind with high affinity to the selected target proteins.

Pfizer will pay a technology access fee and additional success-based payments for each target protein of interest, the companies said in a statement.

[Image courtesy: Atomwise]

Just in

Seed

Oso Semiconductor raises $5.2M

Oso Semiconductor has raised $5.2 million in seed funding. The round was led by Engine Ventures.
People

Battelle appoints Tim Ryan to board of directors

Battelle has elected Tim Ryan, Citi’s Head of Technology and Business Enablement, to its board of directors.
Around the web

OpenAI launches ChatGPT Gov for U.S. government agencies — CNBC

It’s called ChatGPT Gov and was built specifically for U.S. government use; writes Hayden Field. 
Around the web

DeepSeek’s popular AI app is explicitly sending US data to China — Wired

Users have already reported several examples of DeepSeek censoring content that is critical of China or its policies, writes Matt Burgess and Lily Hay Newman. 
Around the web

DeepSeek hit with large-scale cyberattack, says it’s limiting registrations — CNBC

DeepSeek on Monday said it would temporarily limit user registrations “due to large-scale malicious attacks” on its services; writes Hayden Field.